Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market
29 oct. 2024 09h00 HE
|
Alira Health
Framingham, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm dedicated to humanizing life sciences, today announced the release of its 2024 Global...
Biosimilar Contract Manufacturing Market Size to Hit USD 26.1 Billion by 2032 at 18.90% CAGR – Report by Market Research Future (MRFR)
24 juil. 2023 07h34 HE
|
Market Research Future
New York, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Biosimilar Contract Manufacturing Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biosimilar...
Adalimumab Biosimilar Market Expand Lucratively & Grow at a CAGR of 23.2% to 2031 | Says Latest InsightAce Study
06 avr. 2023 06h44 HE
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, April 06, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Adalimumab Biosimilar Market- (By Product...
Global Biosimilar Market to Gather $83,836.40 Million by 2028, Growing at a CAGR of 24.90% in the 2021-2028 Timeframe [170-Pages] | Issued by Research Dive
03 janv. 2023 09h02 HE
|
Research Dive
New York, USA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global biosimilar market is expected to gather a revenue of $83,836.40 million by...
Global Biosimilar Market to Generate a Revenue of $83,836.40 Million by 2028, Growing at a CAGR of 24.90% from 2021 to 2028 | Exclusively Available [170-Pages] by Research Dive
29 mars 2022 09h00 HE
|
Research Dive
New York, USA, March 29, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global biosimilar market is expected to garner a revenue of $83,836.40 million by 2028,...